Back

Aspirin reloading before percutaneous coronary intervention on chronic aspirin therapy: reduced early ischemia without bleeding trade-off

29 August 2025 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Wenbo Dai

2nd Hospital of Tianjin Medical University, Tianjin (China)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
Professor D. Capodanno (Catania, IT)
Slides Video
Presentation thumbnail
Impact of antiplatelet pretreatment on stent thrombosis in patients undergoing PCI in real world practice: insight France PCI registry
Doctor G. Range (Chartres, FR)
Abstract Slides Video
Presentation thumbnail
A shorter duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials
Doctor T. Fretz (Indianapolis, US)
Abstract Slides Video
Presentation thumbnail
12- vs. 1-month DAPT: comparative outcomes after aspirin cessation with HT supreme stent
Doctor T. Tsai (Galway, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 08:51 CET
You may be interested in
thumbnail
Congress Session
Adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Session
HOT LINE 6
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources